Stephanie Bezzina Wettinger Selected Research

hemoglobin F Malta I

1/2007	A review of cis-trans interplay between DNA sequences 5' to the (G)gamma- and beta-globin genes among Hb F-Malta-I heterozygotes/homozygotes and beta-thalassemia homozygotes/compound heterozygotes, and the effects of hydroxyurea on the Hb F/F-erythrocyte; the need for large multicenter trials.
1/2007	Developmental effect of the XmnI site on Ggamma-globin gene expression among newborn Hb F-Malta-I [Ggamma117(G19)His-->Arg, CAT-->CGT] heterozygotes and adult beta+ -Thalassemia homozygotes.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stephanie Bezzina Wettinger Research Topics

Disease

3	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 03/2005
3	Inflammation (Inflammations) 01/2017 - 03/2005
3	Myocardial Infarction 01/2017 - 03/2005
2	beta-Thalassemia (Cooley's Anemia) 01/2007 - 01/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2021
1	Heart Failure 10/2021
1	Parkinson Disease (Parkinson's Disease) 12/2014
1	Venous Thrombosis (Deep-Vein Thrombosis) 03/2009
1	Thalassemia 01/2007

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2005
2	Messenger RNA (mRNA)IBA 03/2009 - 03/2005
2	GlobinsIBA 01/2007 - 01/2007
2	hemoglobin F Malta IIBA 01/2007 - 01/2007
1	RNA (Ribonucleic Acid)IBA 10/2021
1	LipidsIBA 01/2017
1	Tobacco Smoke Pollution (Passive Smoking)IBA 01/2017
1	Proteins (Proteins, Gene)FDA Link 12/2014
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 03/2009
1	Interleukin-1 (Interleukin 1)IBA 03/2009
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2007
1	beta-Globins (beta Globin)IBA 01/2007
1	gamma-GlobinsIBA 01/2007
1	C-Reactive ProteinIBA 03/2005
1	InterleukinsIBA 03/2005

Therapy/Procedure

2	Therapeutics 10/2021 - 01/2019